Target intelligence / Profile preview

Phosphatidylinositol glycan anchor biosynthesis class G protein (PIGG)

Target
PIGG
Molecular classification
Enzyme, Transferase, Glycosylphosphatidylinositol-anchor biosynthesis enzyme
01

Overview

Phosphatidylinositol glycan anchor biosynthesis class G protein (PIGG) is an endoplasmic reticulum (ER)-localized enzyme that functions as the catalytic subunit of the ethanolamine phosphate transferase 2 complex[5][1]. PIGG transfers an ethanolamine phosphate group from phosphatidylethanolamine to the second mannose residue during biosynthesis of glycosylphosphatidylinositol (GPI) anchors, which attach certain proteins to the cell surface[5][1][3]. Over 150 proteins require GPI anchors for membrane localization and function, impacting a wide range of developmental and physiological processes, particularly in the nervous system[3][1]. Pathogenic variants in PIGG cause inherited GPI deficiency, resulting in neurodevelopmental disorders characterized by intellectual disability, hypotonia, early-onset seizures, cerebellar atrophy, and (in some cases) mitochondrial dysfunction[1][3]. Fibroblasts from patients often show reduced levels of specific GPI-anchored proteins, especially CD73, providing a functional biomarker[3]. Currently, no drugs are documented for direct modulation of PIGG activity, and owing to its fundamental role in cell biology, it is a potential but high-risk therapeutic target[5][3][1].

Other names
GPI ethanolamine phosphate transferase 2, catalytic subunitGPI7hGPI7PIG-GFLJ20265LAS21MRT53NEDHSCAPRO4405RLGS1930EMM blood group antigenGPI7 homologLAS21 (GPI7) homolog (S. cerevisiae)EMM
02

Biological functions

GPI-anchor biosynthesisPost-translational protein modificationCell surface protein anchoringNeural development
03

Disease associations

Inherited GPI deficiencyNeurodevelopmental disordersIntellectual disabilityHypotoniaSeizure disordersCerebellar atrophy
04

Safety considerations

Possible neurodevelopmental toxicity/risk with inhibitionbroad systemic impact due to role in GPI-anchored protein attachment
05

Biomarkers

CD73 (in fibroblasts, as reduced CD73 levels are noted in PIGG-deficiency)GPI-anchored protein levels in fibroblasts

Beyond the preview

Go deeper on Phosphatidylinositol glycan anchor biosynthesis class G protein (PIGG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phosphatidylinositol glycan anchor biosynthesis class G protein (PIGG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call